Derek Hicks
Fortuna: 842 483 $ al 31/05/2026
Fortuna: 842 483 $ al 31/05/2026
Derek Hicks currently works at Rezo Therapeutics, Inc., as Chief Executive Officer from 2025.
Mr. Hicks also formerly worked at Spark Therapeutics, Inc., as Head-Business Development from 2020 to 2021 and Intellia Therapeutics, Inc., as Chief Business Officer & Executive Vice President.
Mr. Hicks received his undergraduate degree and graduate degree from the University of Connecticut and Masters Business Admin degree from Kelley School of Business.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/01/2025 | 59.878 ( 0,04 % ) | 842 483 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Director Ejecutivo | 12/08/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01/12/2021 |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Rezo Therapeutics, Inc.
Rezo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.